tbuckley/cabot-search huggingface dataset:
DETERMINANTS OF IMPAIRED LEFT VENTRICULAR SUCTION IN PRE-CAPILLARY PULMONARY HYPERTENSION
Authors: Yasuyuki Chiba, Hiroyuki Iwano, Satonori Tsuneta, Shingo Tsujinaga, Brett Meyers, Pavlos Vlachos, Suguru Ishizaka, Ko Motoi, Hiroyuki Aoyagi, Yoji Tamaki, Asuka Tanemura, Michito Murayama, Shinobu Yokoyama, Masahiro Nakabachi, Hisao Nishino, Sanae Kaga, Kiwamu Kamiya, Hiroshi Ohira, Ichizo Tsujino, Toshihisa Anzai
Journal: Journal of the American College of Cardiology (2022)
REGULAR COFFEE INTAKE IS ASSOCIATED WITH IMPROVED MORTALITY IN PREVALENT CARDIOVASCULAR DISEASE
Authors: Peter M. Kistler, David Chieng, Rodrigo Canovas, David M. Kaye, Joseph B. Morton, Geoffrey Lee, Liang-han Ling, Sandeep Prabhu, Aleksandr Voskoboinik, Hariharan Sugumar, Louise Segan, Jonathan M. Kalman
Journal: Journal of the American College of Cardiology (2022)
Predicting the Onset of Hepatitis B Virus–Related Acute-on-Chronic Liver Failure
Authors: Jinjin Luo, Xi Liang, Jiaojiao Xin, Jiaqi Li, Peng Li, Qian Zhou, Shaorui Hao, Huafen Zhang, Yingyan Lu, Tianzhou Wu, Lingling Yang, Jiang Li, Tan Li, Keke Ren, Beibei Guo, Xingping Zhou, Jiaxian Chen, Lulu He, Hui Yang, Wen Hu, Shaoli You, Shaojie Xin, Jing Jiang, Dongyan Shi, Xin Chen, Jun Li
Journal: Clinical Gastroenterology and Hepatology (2022)
Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting
Authors: Yang Liu, Guillaume Méric, Aki S. Havulinna, Shu Mei Teo, Fredrik Åberg, Matti Ruuskanen, Jon Sanders, Qiyun Zhu, Anupriya Tripathi, Karin Verspoor, Susan Cheng, Mohit Jain, Pekka Jousilahti, Yoshiki Vázquez-Baeza, Rohit Loomba, Leo Lahti, Teemu Niiranen, Veikko Salomaa, Rob Knight, Michael Inouye
Journal: Cell Metabolism (2022)

The gut microbiome has shown promise as a predictive biomarker for various diseases. However, the potential of gut microbiota for prospective risk prediction of liver disease has not been assessed. Here, we utilized shallow shotgun metagenomic sequencing of a large population-based cohort (N > 7,000) with ∼15 years of follow-up in combination with machine learning to investigate the predictive capacity of gut microbial predictors individually and in conjunction with conventional risk factors for incident liver disease. Separately, conventional and microbial factors showed comparable predictive capacity. However, microbiome augmentation of conventional risk factors using machine learning significantly improved the performance. Similarly, disease-free survival analysis showed significantly improved stratification using microbiome-augmented models. Investigation of predictive microbial signatures revealed previously unknown taxa for liver disease, as well as those previously associated with hepatic function and disease. This study supports the potential clinical validity of gut metagenomic sequencing to complement conventional risk factors for prediction of liver diseases.
ASSESSMENT FOR CHANGE IN ECHOCARDIOGRAPHIC LEFT VENTRICULAR GLOBAL LONGITUDINAL STRAIN PATTERN FOLLOWING A TRANSCATHETER AORTIC VALVE REPLACEMENT
Authors: Akarsh Parekh, Anila Rao, Lakshmi G. Rao, Melissa Marie Ianitelli, Mark A. Zainea
Journal: Journal of the American College of Cardiology (2022)
Correction: PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis
Authors: Debangshu Samanta, Youngrok Park, Shaida A. Andrabi, Laura M. Shelton, Daniele M. Gilkes, Gregg L. Semenza
Journal: Cancer Research (2022)

In the original version of this article (1), there was an error in Fig. 7F.Specifically, photomicrographs of a lung section from the same mouse (M2) injected with sh4 knockdown cells were inadvertently presented as lung sections from mice M1 and M2.The correct images have been provided, and the error has been corrected in the latest online HTML and PDF version of the article.The authors regret this error.
THE PROGNOSTIC VALUE OF PLAQUE IN PATIENTS WITH ACUTE CHEST PAIN
Authors: Mohammed Meah, Evangelos Tzolos, Kang-Liang Wang, Anda Bularga, Marc Dweck, Nick Curzen, Attila Kardos, Liza Keating, Robert F. Storey, Nicholas L. Mills, Damini Dey, Piotr Slomka, David E. Newby, Alasdair Gray, Michelle C. Williams, Carl Roobottom
Journal: Journal of the American College of Cardiology (2022)
IMPROVED QUANTITATIVE SPECT MYOCARDIAL PERFUSION IMAGING USING DEEP LEARNING-BASED ATTENUATION CORRECTION
Authors: Tomoe Hagio, Alexis Poitrasson-Rivière, Jonathan B. Moody, Jennifer M. Renaud, Liliana Arida-Moody, Ravi V. Shah, Edward P. Ficaro, Venkatesh Locharla Murthy
Journal: Journal of the American College of Cardiology (2022)
TEN YEAR OUTCOMES AFTER PACLITAXEL-COATED BALLOON ANGIOPLASTY FOR DRUG ELUTING STENT RESTENOSIS
Authors: Ryo Bando, Masanobu Ohya, Takeshi Tada, Hiroyuki Tanaka, Yasushi Fuku, Kazushige Kadota
Journal: Journal of the American College of Cardiology (2022)
In situ antigen modification-based target-redirected universal chimeric antigen receptor T (TRUE CAR-T) cell therapy in solid tumors
Authors: Zhichen Sun, Rutian Li, Yun Shen, Siyi Tan, Naiqing Ding, Ruihan Xu, Xinyue Wang, Jia Wei, Baorui Liu, Fanyan Meng
Journal: Journal of Hematology & Oncology (2022)

Abstract Background Chimeric antigen receptor (CAR)-T cell therapy has demonstrated remarkable success in the treatment of hematologic malignancies, while the success has not yet been replicated in solid tumors. To some extent, the disappointing results can be attributed to the paucity and heterogeneity of target antigens in solid tumors since adequate antigens are the cornerstone for CAR-T cells to recognize and attack tumor cells. Methods We established a target-redirected universal CAR-T (TRUE CAR-T) cell therapeutic modality, in which exogenous antigens are loaded onto fusogenic nanoparticles to achieve in situ modification of cell membrane in solid tumors, providing targets for subsequent CAR-T cell therapy. The modification effect was evaluated by flow cytometry and confocal microscopic imaging. The in vivo metabolism and biodistribution of fusogenic antigen loaded nanoparticles (F-AgNPs) was explored using near infrared living imaging. Then F-AgNPs mediated in situ antigen modification were cooperated with corresponding CAR-T cell therapy, and its antitumor efficacy was evaluated using immune function experiments and further investigated in different tumor models. Results Using F-AgNPs, exogenous antigens were selectively modified onto tumor cell membranes through membrane fusion, spread deeper into tumor tissues through intercellular lipid transfer, further activating corresponding CAR-T cells and mediating antitumor immune responses towards multiple types of tumor cells, despite of their inherent antigen profiles. The cooperative treatment of F-AgNPs and CAR-T cell therapy successfully suppressed tumor proliferation and prolonged survival in both subcutaneous and peritoneally disseminated tumor models. Conclusion The fusogenic nanoparticle-based in situ antigen modification overcome the limitation of target antigens paucity and heterogeneity in solid tumors, improving the efficacy and broadening the applications of CAR-T cells, thus establishing a novel TRUE CAR-T cell therapeutic modality with universal application and translational potential in immunotherapies for solid tumors.
COMPREHENSIVE COMPARATIVE EFFECTIVENESS AND SAFETY OF FIRST-LINE CALCIUM CHANNEL BLOCKER MONOTHERAPY IN HYPERTENSIVE PATIENTS: A LARGE-SCALE MULTINATIONAL PARTICIPANT-LEVEL ASSESSMENT
Authors: Yuan Lu, Rohan Khera, Yuntian Liu, Ruijun Chen, Martijn Schuemie, George Hripcsak, Marc Suchard, Harlan M. Krumholz
Journal: Journal of the American College of Cardiology (2022)
Influence of vaccination and prior immunity on the dynamics of Omicron BA.1 and BA.2 sub-variants
Authors: Chloé Dimeglio, Jean-Michel Loubes, Marion Migueres, Karine Sauné, Pauline Trémeaux, Sébastien Lhomme, Noémie Ranger, Justine Latour, Jean-Michel Mansuy, Jacques Izopet
Journal: Journal of Infection (2022)
INCIDENCE, PREDICTORS, AND CLINICAL IMPACT OF RECOVERY IN LEFT VENTRICULAR SYSTOLIC FUNCTION AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION IN THE STS/ACC TVT REGISTRY
Authors: Siddharth Patel, Anubodh Varshney, Amanda Stebbins, Adam J. Nelson, Sreekanth Vemulapalli, Tsuyoshi Kaneko, Deepak L. Bhatt
Journal: Journal of the American College of Cardiology (2022)
Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients
Authors: Maddalena Peghin, Maria De Martino, Alvisa Palese, Valentina Gerussi, Giulia Bontempo, Elena Graziano, Erica Visintini, Denise D'Elia, Fabiana Dellai, Francesco Marrella, Martina Fabris, Francesco Curcio, Assunta Sartor, Miriam Isola, Carlo Tascini
Journal: Clinical Microbiology and Infection (2022)
Characterization of INCB086550: A Potent and Novel Small-Molecule PD-L1 Inhibitor
Authors: Holly K. Koblish, Liangxing Wu, Liang-Chuan S. Wang, Phillip C.C. Liu, Richard Wynn, Jonathan Rios-Doria, Susan Spitz, Hao Liu, Alla Volgina, Nina Zolotarjova, Kanishk Kapilashrami, Elham Behshad, Maryanne Covington, Yan-ou Yang, Jingwei Li, Sharon Diamond, Maxim Soloviev, Kevin O'Hayer, Stephen Rubin, Chrysi Kanellopoulou, Gengjie Yang, Mark Rupar, Darlise DiMatteo, Luping Lin, Christina Stevens, Yue Zhang, Pramod Thekkat, Ryan Geschwindt, Cindy Marando, Swamy Yeleswaram, Jeff Jackson, Peggy Scherle, Reid Huber, Wenqing Yao, Gregory Hollis
Journal: Cancer Discovery (2022)

Blocking the activity of the programmed cell death protein 1 (PD-1) inhibitory receptor with therapeutic antibodies against either the ligand (PD-L1) or PD-1 itself has proven to be an effective treatment modality for multiple cancers. Contrasting with antibodies, small molecules could demonstrate increased tissue penetration, distinct pharmacology, and potentially enhanced antitumor activity. Here, we describe the identification and characterization of INCB086550, a novel, oral, small-molecule PD-L1 inhibitor. In vitro, INCB086550 selectively and potently blocked the PD-L1/PD-1 interaction, induced PD-L1 dimerization and internalization, and induced stimulation-dependent cytokine production in primary human immune cells. In vivo, INCB086550 reduced tumor growth in CD34+ humanized mice and induced T-cell activation gene signatures, consistent with PD-L1/PD-1 pathway blockade. Preliminary data from an ongoing phase I study confirmed PD-L1/PD-1 blockade in peripheral blood cells, with increased immune activation and tumor growth control. These data support continued clinical evaluation of INCB086550 as an alternative to antibody-based therapies. We have identified a potent small-molecule inhibitor of PD-L1, INCB086550, which has biological properties similar to PD-L1/PD-1 monoclonal antibodies and may represent an alternative to antibody therapy. Preliminary clinical data in patients demonstrated increased immune activation and tumor growth control, which support continued clinical evaluation of this approach. See related commentary by Capparelli and Aplin, p. 1413. This article is highlighted in the In This Issue feature, p. 1397.
BLINDED COMPARISON OF WATCHMAN FLX DEVICE PASS CRITERIA ASSESSMENT AND DEVICE RELEASE OR CAPTURE DECISION MAKING USING FLUOROSCOPY AND ANGIOGRAPHY ALONE VS THE GOLD STANDARD TRANSESOPHAGEAL ECHOCARDIOGRAPHY APPROACH
Authors: Safwan Kassas, Peter Fattal, Brenda Wagner, Jennifer Thurston, Christopher Bosman, Brandi Horgan, Robert Allen
Journal: Journal of the American College of Cardiology (2022)
Genetic, Molecular, and Cellular Determinants of Sex-Specific Cardiovascular Traits
Authors: Felix Vaura, Joonatan Palmu, Jenni Aittokallio, Anni Kauko, Teemu Niiranen
Journal: Circulation Research (2022)

Despite the well-known sex dimorphism in cardiovascular disease traits, the exact genetic, molecular, and cellular underpinnings of these differences are not well understood. A growing body of evidence currently points at the links between cardiovascular disease traits and the genome, epigenome, transcriptome, and metabolome. However, the sex-specific differences in these links remain largely unstudied due to challenges in bioinformatic methods, inadequate statistical power, analytic costs, and paucity of valid experimental models. This review article provides an overview of the literature on sex differences in genetic architecture, heritability, epigenetic changes, transcriptomic signatures, and metabolomic profiles in relation to cardiovascular disease traits. We also review the literature on the associations between sex hormones and cardiovascular disease traits and discuss the potential mechanisms underlying these associations, focusing on human studies.
Re: Effect of Immunotherapy Time-of-day Infusion on Overall Survival Among Patients with Advanced Melanoma in the USA (MEMOIR): A Propensity Score-matched Analysis of a Single-centre, Longitudinal Study
Authors: Matteo Santoni, Javier Molina-Cerrillo, Francesco Massari, Rodolfo Montironi, Enrique Grande
Journal: European Urology (2022)
Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study
Authors: Matthew H. Taylor, Courtney B. Betts, Lauren Maloney, Eric Nadler, Alain Algazi, Michael J. Guarino, John Nemunaitis, Antonio Jimeno, Priti Patel, Veerendra Munugalavadla, Lin Tao, Douglas Adkins, Jerome H. Goldschmidt, Ezra E.W. Cohen, Lisa M. Coussens
Journal: Clinical Cancer Research (2021)

Abstract Purpose: Programmed cell death-1 (PD-1) receptor inhibitors have shown efficacy in head and neck squamous cell carcinoma (HNSCC), but treatment failure or secondary resistance occurs in most patients. In preclinical murine carcinoma models, inhibition of Bruton's tyrosine kinase (BTK) induces myeloid cell reprogramming that subsequently bolsters CD8+ T cell responses, resulting in enhanced antitumor activity. This phase 2, multicenter, open-label, randomized study evaluated pembrolizumab (anti–PD-1 monoclonal antibody) plus acalabrutinib (BTK inhibitor) in recurrent or metastatic HNSCC. Patients and Methods: Patients received pembrolizumab 200 mg intravenously every 3 weeks, alone or in combination with acalabrutinib 100 mg orally twice daily. Safety and overall response rate (ORR) were co-primary objectives. The secondary objectives were progression-free survival (PFS) and overall survival. Results: Seventy-six patients were evaluated (pembrolizumab, n = 39; pembrolizumab + acalabrutinib, n = 37). Higher frequencies of grade 3–4 treatment-emergent adverse events (AE; 65% vs. 39%) and serious AEs (68% vs. 31%) were observed with combination therapy versus monotherapy. ORR was 18% with monotherapy versus 14% with combination therapy. Median PFS was 2.7 [95% confidence interval (CI), 1.4–6.8] months in the combination arm and 1.7 (95% CI, 1.4–4.0) months in the monotherapy arm. The study was terminated due to lack of clinical benefit with combination treatment. To assess how tumor immune contexture was affected by therapy in patients with pre- and post-treatment biopsies, spatial proteomic analyses were conducted that revealed a trend toward increased CD45+ leukocyte infiltration of tumors from baseline at day 43 with pembrolizumab (monotherapy, n = 5; combination, n = 2), which appeared to be higher in combination-treated patients; however, definitive conclusions could not be drawn due to limited sample size. Conclusions: Despite lack of clinical efficacy, immune subset analyses suggest that there are additive effects of this combination; however, the associated toxicity limits the feasibility of combination treatment with pembrolizumab and acalabrutinib in patients with recurrent or metastatic HNSCC.
IMPACT OF RENAL FUNCTION ON ANTI-FACTOR XA ACTIVITY VALUES WITH EDOXABAN USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
Authors: Ryohei Ono, Kenichi Fukushima, Hidehisa Takahashi, Yasuhiko Hori, Yoshio Kobayashi
Journal: Journal of the American College of Cardiology (2022)
UNSUPERVISED MACHINE LEARNING IDENTIFIES PHENOTYPES FOR ATRIAL FIBRILLATION THAT PREDICT ACUTE ABLATION SUCCESS
Authors: Brototo Deb, Prasanth Ganesan, Ruibin Feng, Neal K. Bhatia, Albert J. Rogers, Samuel Ruiperez-Campillo, Paul Clopton, Sanjiv M. Narayan
Journal: Journal of the American College of Cardiology (2022)
CIRCULATING BIOMARKER PATTERNS IN PATIENTS WITH VASODILATORY CARDIOGENIC SHOCK IN THE CARDIAC INTENSIVE CARE UNIT: ANALYSIS FROM THE CRITICAL CARE CARDIOLOGY TRIALS NETWORK (CCCTN) REGISTRY
Authors: Balimkiz Senman, Mathew Lopes, Danuzia Silva, Fagundes Antonio, David Berg, Ankeet Bhatt, Kayleigh Butler, Petr Jarolim, Michael W. Levangie, Minao Tang, Anubodh Varshney, David A. Morrow, Erin Ann Bohula
Journal: Journal of the American College of Cardiology (2022)
OUTRACING CANCER: ANALYZING RACIAL DIFFERENCES IN CLINICAL CHARACTERISTICS AND OUTCOMES IN720 PATIENTS WITHPRIMARY MALIGNANT CARDIAC TUMORS FROM THE SEER DATABASE
Authors: Sanskriti Shrivastava, Mark M Aloysius, Hamza Hanif, Raza Naseer, Ayla Benge, Milos Babic, Pranjal Kumar Boruah
Journal: Journal of the American College of Cardiology (2022)
NEUTROPHIL-LYMPHOCYTE RATIO AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION: ANALYSES FROM ENGAGE AF-TIMI 48 TRIAL
Authors: Antonio Fagundes, Christian Ruff, David A. Morrow, Sabina A. Murphy, Michael G. Palazzolo, Cathy Z. Chen, Elliott M. Antman, Eugene Braunwald, Robert P. Giugliano
Journal: Journal of the American College of Cardiology (2022)
BEHIND THE SCREEN: A RETROSPECTIVE COMPARATIVE ANALYSIS OF CONGESTIVE HEART FAILURE EXACERBATION ADMISSIONS, FOLLOW UP AND MANAGEMENT DURING THE COVID19 PANDEMIC AND PRE PANDEMIC
Authors: Philip Chebaya, Harvir Gambhir, Sanchari Banerjee, Atika Azhar, Nick Huang, VIshal Phogat, Kevin Smith, Luke Sala, Soumya Adhikari, Kennedy Nye
Journal: Journal of the American College of Cardiology (2022)
LEFT VENTRICULAR OUTFLOW TRACT CALCIFICATION AND TRANSCATHETER AORTIC VALVE REPLACEMENT PROCEDURAL OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS
Authors: Chol Techorueangwiwat, Chanavuth Kanitsoraphan, Jason Kuniyoshi, Parthav Shah, Ricky Huang, Witina Techasatian, Somsupha Kanjanauthai
Journal: Journal of the American College of Cardiology (2022)
FULMINANT RECURRENT PERICARDITIS, POSSIBLY RELATED TO CORONAVIRUS VACCINATION. OR IS IT ?
Authors: Shmuel Schwartzenberg, Yuri Peysakhovich, Yaron Shapira, Victor Rubachevsky, Muhamad Mahamid, Ran Kornowski, Dan Aravot, Ram Sharony
Journal: Journal of the American College of Cardiology (2022)
Mapping heterogenous anisotropic tissue mechanical properties with transverse isotropic nonlinear inversion MR elastography
Authors: Matthew McGarry, Elijah Van Houten, Damian Sowinski, Dhrubo Jyoti, Daniel R. Smith, Diego A. Caban-Rivera, Grace McIlvain, Philip Bayly, Curtis L. Johnson, John Weaver, Keith Paulsen
Journal: Medical Image Analysis (2022)
THE COMPARATIVE EFFECT OF NEWER ANTIDIABETIC AGENTS ON ENDOTHELIAL FUNCTION AND ARTERIAL WALL PROPERTIES IN PATIENTS WITH TYPE 2 DIABETES
Authors: Evanthia Bletsa, Panagiota K. Stampouloglou, Gerasimos Siasos, Evangelos Oikonomou, Nikolaos Gouliopoulos, Vasiliki Tsigkou, Stavroula Paschou, Eva Kassi, Nikolaos Tentolouris, SR, Konstantinos Tsioufis, Emmanouil Vavouranakis
Journal: Journal of the American College of Cardiology (2022)
Exercise Blood Pressure in Heart Failure With Preserved and Reduced Ejection Fraction
Authors: Mayooran Namasivayam, Emily S Lau, Emily K Zern, Mark W Schoenike, Kathryn M Hardin, John A Sbarbaro, Thomas F Cunningham, Robyn M Farrell, Jennifer Rouvina, Alyssa Kowal, Rohan R Bhat, Liana C Brooks, Matthew Nayor, Ravi V Shah, Jennifer E Ho, Rajeev Malhotra, Gregory D Lewis
Journal: JACC Heart Failure (2022)
Abstract P5-14-12: Health literacy among long term breast cancer survivors; exploring associated factors in a nation-wide sample
Authors: Kathrine Flørenes Vandraas, Kristin V Reinertsen, Cecilie E Kiserud, Synne K Bøhn, Hanne C Lie
Journal: Cancer Research (2022)

Abstract Objectives: Low health literacy (HL) levels likely hamper health management and outcomes in cancer survivorship. Knowledge of associated factors is needed to identify at-risk sub-groups of survivors, but is currently scant. Here, we explore HL-levels and associated factors in a nation-wide sample of long-term BCSs. Methods: All BCSs aged 20-65 years, diagnosed with early-stage BC in 2011-2012, were identified through the Norwegian Cancer Registry and invited to participate in the Survivorship, Work and Sex (SWEET)-study. HL was measured using The European Health Literacy Survey Questionnaire-12 (HLS-EU-Q12) as a continuous and categorical variable. Associations between HL and sociodemographic-, physical- and mental health variables, including the most common LEs, were explored in uni- and multivariable linear regression models. Results: The final sample consisted of 1355 survivors (48%). Median age was 60 years and the majority of survivors had high socioeconomic status (SES). Median HL sum-score corresponded to an intermediate HL level (36.2, SD 5.4), while 19.3% reported marginal or inadequate HL. Education, income, age at diagnosis, the personality trait neuroticism and fear of cancer recurrence (FCR) remained significantly associated with HL in the multivariate model, explaining 12% of the variance in HL scores. Conclusion: Low levels of HL were prevalent, potentially affecting the provision of effective survivorship care and BCS’s self-management abilities. Identifying individuals at risk of low HL based on knowledge readily available to clinicians remains challenging and warrants further investigation. Implications for cancer survivors: Addressing survivors’ HL could be a key target for improving survivorship care. Citation Format: Kathrine Flørenes Vandraas, Kristin V Reinertsen, Cecilie E Kiserud, Synne K Bøhn, Hanne C Lie. Health literacy among long term breast cancer survivors; exploring associated factors in a nation-wide sample [abstract]. In: Proceedings of the 2021 San Antonio Breast Cancer Symposium; 2021 Dec 7-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2022;82(4 Suppl):Abstract nr P5-14-12.
LONG-TERM OUTCOMES OF PATIENTS WITH SINGLE VENTRICLE WHO DO NOT UNDERGO FONTAN PALLIATION
Authors: Wayne Zheng, Yves d'Udekem, Leeanne Grigg, Dominica Zentner, Rachel Cordina, David Celermajer, Edward Buratto, Igor Konstantinov, Melissa Lee
Journal: Journal of the American College of Cardiology (2022)
TELE-BASED VIRTUAL BP MANAGEMENT BY PHARMACIST OR NURSE PRACTITIONER VERSUS OFFICE-BASED PCP LED INTERVENTION IN MANAGEMENT OF SYSTOLIC BP. A SYSTEMATIC REVIEW AND META-ANALYSIS
Authors: Nischit Baral, Sri Lakshmi Pratyusha Javvadi, Basel Abdelazeem, Ashiya Khan, Deepti Nagaraja Rao, Krishna Prasad Bashyal, Rohit Rauniyar, Govinda Adhikari, Calvin Ghimire, Khaing Khaing Htwe, Kazim Aykent, Arvind Kunadi, Hafiz Khan, Mahin R. Khan
Journal: Journal of the American College of Cardiology (2022)
Covid-19: Hospital admissions rise as cases increase in over 55s
Authors: Gareth Iacobucci
Journal: BMJ (2022)

Covid-19: Hospital admissions rise as cases increase in over 55s Gareth IacobucciEngland has seen a rise in covid related hospital admissions in the past week, data show.This came as a study showed that covid cases are rising among the over 55s in England, prompting warnings from experts that the pandemic is not over.
DIET, ANGIOGRAPHIC CORONARY DISEASE, AND CARDIOVASCULAR OUTCOMES IN WOMEN
Authors: Brandon Schwartz, So Yung Choi, Galen Cook-Wiens, Sheryl Foulke Kelsey, Pankaj Malhotra, Eileen M. Handberg, Steven E. Reis, William J. Rogers, Barry L. Sharaf, George Sopko, Anne Matthews, Yasmeen Taha, Monica Aggarwal, Carl J. Pepine, C. Noel Bairey Merz
Journal: Journal of the American College of Cardiology (2022)